Reference health

Anticancer Activity of Metformin: A Systematic Review of the Literature

https://doi.org/10.2144/fsoa-2019-0053
CiteStamped reference-health badge
62/62 checkable references clean · checked 2026-07-24

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

12 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 62 checked references that resolve
resolves10.1002/jcp.21986
High glucose increases expression of cyclooxygenase‐2, increases oxidative stress and decreases the generation of nitric oxide in mouse microvessel endothelial cells
resolves10.1002/jcp.21063
Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells
resolves10.1542/peds.2003-0649-F
Insulin Sensitivity Among Obese Children and Adolescents, According to Degree of Weight Loss
resolves10.2337/dc10-0666
Diabetes and Cancer
resolves10.1007/s00125-017-4342-z
The mechanisms of action of metformin
resolves10.1101/gad.17420111
AMP-activated protein kinase—an energy sensor that regulates all aspects of cell function
resolves10.1111/jcpt.12379
Metformin prescription patterns among US adolescents aged 10-19 years: 2009-2013
resolves10.1016/j.pcd.2018.02.004
Update on off label use of metformin for obesity
resolves10.18632/oncotarget.8194
Repurposing metformin for cancer treatment: current clinical studies
resolves10.7326/0003-4819-151-4-200908180-00136
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
resolves10.1158/0008-5472.CAN-06-1500
Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells
resolves10.4161/cc.11.2.18813
Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
resolves10.7150/ijbs.29689
Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2
resolves10.1186/s13046-019-1090-6
Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASK1 via mitochondrial and endoplasmic reticulum stress-associated pathways
resolves10.1158/1541-7786.MCR-18-0409
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer
resolves10.1016/j.canlet.2019.02.014
Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis
resolves10.3390/cancers11020209
Metformin Treatment Suppresses Melanoma Cell Growth and Motility Through Modulation of microRNA Expression
resolves10.1371/journal.pone.0192759
Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer
resolves10.1016/j.cell.2016.11.055
An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer
resolves10.1016/j.bbagen.2014.01.023
The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: Implications for cancer therapy and prevention
resolves10.1186/s12943-017-0701-0
Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
resolves10.1136/bmj.38415.708634.F7
Metformin and reduced risk of cancer in diabetic patients
resolves10.1093/humrep/des203
Cleavage of endometrial  -integrins into their functional forms is mediated by proprotein convertase 5/6
resolves10.1126/science.1120781
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
resolves10.1016/j.cmet.2004.12.003
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
resolves10.1530/ERC-15-0402
Glucose-deprivation increases thyroid cancer cells sensitivity to metformin
resolves10.1038/nrc2981
Regulation of cancer cell metabolism
resolves10.1016/S0735-1097(01)01630-8
Improved endothelial function with metformin in type 2 diabetes mellitus
resolves10.1042/BST20110602
Sphingosine 1-phosphate signalling in cancer
resolves10.2174/138945008785132402
Targeting SphK1 as a New Strategy against Cancer
resolves10.1038/381800a0
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
resolves10.1111/1751-2980.12576
Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle‐related proteins
resolves10.29333/ejgm/108679
Metformin: A stroke of luck
resolves10.1111/dom.13262
Epigenetic effects of metformin: From molecular mechanisms to clinical implications
resolves10.1016/j.diabres.2018.05.023
Metformin in cancer
resolves10.1016/j.biopha.2018.03.008
Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells
resolves10.1080/10715762.2018.1485075
Inhibiting ROS-TFE3-dependent autophagy enhances the therapeutic response to metformin in breast cancer
resolves10.1007/s13410-017-0558-1
Current advances in the utilization of nanotechnology for the diagnosis and treatment of diabetes
resolves10.3390/ijms17122000
Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells
resolves10.1016/j.pharep.2017.11.007
Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines
resolves10.1158/1940-6207.CAPR-14-0348
Prevention of Tumor Growth Driven by <i>PIK3CA</i> and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
resolves10.7314/APJCP.2012.13.7.3275
Metformin Inhibits Growth of Hepatocellular Carcinoma Cells by Inducing Apoptosis Via Mitochondrion-mediated Pathway
resolves10.1038/cddis.2011.86
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
resolves10.1042/BCJ20170046
Effect of different γ-subunit isoforms on the regulation of AMPK
resolves10.1002/ijc.28149
Mitochondrial modulation decreases the bortezomib-resistance in multiple myeloma cells
resolves10.1186/s12885-018-4344-3
Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal
resolves10.1016/j.ctrv.2017.01.005
Combination of metformin with chemotherapeutic drugs via different molecular mechanisms
resolves10.1530/ERC-15-0243
Effects of exercise dose on endogenous estrogens in postmenopausal women: a randomized trial
resolves10.18632/oncotarget.6373
Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
resolves10.1089/hum.2018.048
Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout
resolves10.1016/j.gene.2018.04.045
Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway
resolves10.1016/j.tibs.2015.12.001
The Warburg Effect: How Does it Benefit Cancer Cells?
resolves10.1016/j.cmet.2011.07.014
Metabolic Flux and the Regulation of Mammalian Cell Growth
resolves10.4161/cc.20948
Metformin is synthetically lethal with glucose withdrawal in cancer cells
resolves10.1158/0008-5472.CAN-08-2689
Chemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation
resolves10.1038/oncsis.2015.18
Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer
resolves10.1007/978-1-4939-7498-6_22
Measurement of Oxidative Stress: Mitochondrial Function Using the Seahorse System
resolves10.1016/j.virusres.2013.08.002
Hendra and Nipah infection: Emerging paramyxoviruses
resolves10.1038/cddis.2010.31
Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes
resolves10.1074/jbc.RA118.001824
Endoplasmic reticulum (ER) stress–induced reactive oxygen species (ROS) are detrimental for the fitness of a thioredoxin reductase mutant
resolves10.1371/journal.pone.0174486
Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner
resolves10.1038/onc.2011.495
Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia
The 12 references without a DOI — listed, not checked
no DOI — not checkedWexlerDJ. Initial management of blood glucose in adults with type 2 diabetes mellitus. NathanMD (Ed.). UpToDate (2019).
no DOI — not checkedCrowleyMJ DiamantidisCJ McDuffieJRet al.Metformin use in patients with historical contraindications or precautions. Department of Veterans Affairs (US) DC USA (2016). www.ncbi.nlm.nih.gov/books/NBK409374/
no DOI — not checkedDigitalN. Increase in prescriptions for diabetes exceeds rise in overall prescribing (2017). www.digital.nhs.uk
no DOI — not checkedSharmaM , NazarethI , PetersenI. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study. BMJ Open2016(6), 10–12; e010210 (2015).
no DOI — not checkedAromatarisE MunnZ (Eds). Chapter 1: JBI Systematic Reviews. In: Joanna Briggs Institute Reviewer's Manual. The Joanna Briggs Institute (2017).
no DOI — not checkedLuCC , ChiangJH , TsaiFJet al.Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling. Int. J. Oncol.54(4), 1271–1281 (2019).
no DOI — not checkedStevenC PlaxeAJM. Overview of endometrial carcinomaGoffD DizonDS VoraSR FalkSJ (Eds). USA (2019).
no DOI — not checkedMcCullochDavid K. Metformin in the treatment of adults with type 2 diabetes mellitus. FunnellM (Ed.). Sourcebook Inc. IL USA Topic 1809 Version 40.0 (2018).
no DOI — not checkedHeY , TanX , HuHet al.Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway. Oncol. Lett.15(3), 2939–2945 (2018).
no DOI — not checkedLiZ , WangL , LuoNet al.Metformin inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the phosphorylation of Akt. Oncol. Lett.15(5), 7948–7954 (2018).
no DOI — not checkedAljofanM , LoMK , RotaPA , MichalskiWP , MungallBA. Off label antiviral therapeutics for henipaviruses: new light through old windows. J. Antivir. Antiretrovir.2(1), 1–10 (2010).
no DOI — not checkedSuT , LiaoB , DongYet al.Effect of metformin on colorectal carcinoma in type 2 diabetes mellitus patients: a Markov model analysis. Zhonghua Wei Chang Wai Ke Za Zhi20(6), 689–693 (2017).
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2144/fsoa-2019-0053"><img src="https://citestamp.com/citestamped/10.2144/fsoa-2019-0053/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2144/fsoa-2019-0053/badge.svg)](https://citestamp.com/citestamped/10.2144/fsoa-2019-0053)